vs
Solaris Energy Infrastructure, Inc.（SEI）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
Solaris Energy Infrastructure, Inc.的季度营收约是再鼎医药的1.5倍（$196.2M vs $127.1M），再鼎医药同比增速更快（17.1% vs 9.2%），过去两年Solaris Energy Infrastructure, Inc.的营收复合增速更高（63.0% vs 20.8%）
AGL能源有限公司是澳大利亚上市企业，业务涵盖民用及商用电力、天然气的生产与零售，是国家电力市场三大零售商之一。作为澳大利亚最大的电力生产商，该公司同时也是该国最大的碳排放主体。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
SEI vs ZLAB — 直观对比
营收规模更大
SEI
是对方的1.5倍
$127.1M
营收增速更快
ZLAB
高出7.9%
9.2%
两年增速更快
SEI
近两年复合增速
20.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $196.2M | $127.1M |
| 净利润 | $32.1M | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | 25.8% | -54.6% |
| 净利率 | 16.3% | — |
| 营收同比 | 9.2% | 17.1% |
| 净利润同比 | 1013.5% | — |
| 每股收益（稀释后） | $0.32 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SEIZLAB
| Q1 26 | $196.2M | — | ||
| Q4 25 | $179.7M | $127.1M | ||
| Q3 25 | $166.8M | $115.4M | ||
| Q2 25 | $149.3M | $109.1M | ||
| Q1 25 | $126.3M | $105.7M | ||
| Q4 24 | $96.3M | $108.5M | ||
| Q3 24 | $75.0M | $101.8M | ||
| Q2 24 | $73.9M | $100.1M |
净利润SEIZLAB
| Q1 26 | $32.1M | — | ||
| Q4 25 | $-1.7M | — | ||
| Q3 25 | $14.6M | $-36.0M | ||
| Q2 25 | $12.0M | $-40.7M | ||
| Q1 25 | $5.3M | $-48.4M | ||
| Q4 24 | $6.3M | — | ||
| Q3 24 | $-968.0K | $-41.7M | ||
| Q2 24 | $6.2M | $-80.3M |
毛利率SEIZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 60.6% | ||
| Q1 25 | — | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% |
营业利润率SEIZLAB
| Q1 26 | 25.8% | — | ||
| Q4 25 | 22.2% | -54.6% | ||
| Q3 25 | 22.7% | -42.3% | ||
| Q2 25 | 23.8% | -50.3% | ||
| Q1 25 | 17.5% | -53.3% | ||
| Q4 24 | 26.7% | -62.6% | ||
| Q3 24 | 7.0% | -66.6% | ||
| Q2 24 | 16.0% | -76.0% |
净利率SEIZLAB
| Q1 26 | 16.3% | — | ||
| Q4 25 | -0.9% | — | ||
| Q3 25 | 8.7% | -31.2% | ||
| Q2 25 | 8.0% | -37.3% | ||
| Q1 25 | 4.2% | -45.8% | ||
| Q4 24 | 6.5% | — | ||
| Q3 24 | -1.3% | -40.9% | ||
| Q2 24 | 8.4% | -80.2% |
每股收益（稀释后）SEIZLAB
| Q1 26 | $0.32 | — | ||
| Q4 25 | — | $-0.05 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | — | $-0.04 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | — | $-0.09 | ||
| Q3 24 | — | $-0.04 | ||
| Q2 24 | — | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $344.5M | $689.6M |
| 总债务越低越好 | $395.4M | — |
| 股东权益账面价值 | — | $715.5M |
| 总资产 | — | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资SEIZLAB
| Q1 26 | $344.5M | — | ||
| Q4 25 | $353.3M | $689.6M | ||
| Q3 25 | $106.7M | $717.2M | ||
| Q2 25 | $99.6M | $732.2M | ||
| Q1 25 | $16.7M | $757.3M | ||
| Q4 24 | $114.3M | $779.7M | ||
| Q3 24 | $18.6M | $616.1M | ||
| Q2 24 | $5.1M | $630.0M |
总债务SEIZLAB
| Q1 26 | $395.4M | — | ||
| Q4 25 | $184.0M | — | ||
| Q3 25 | $382.8M | — | ||
| Q2 25 | $386.2M | — | ||
| Q1 25 | $316.2M | — | ||
| Q4 24 | $315.7M | — | ||
| Q3 24 | $315.3M | — | ||
| Q2 24 | — | — |
股东权益SEIZLAB
| Q1 26 | — | — | ||
| Q4 25 | $564.3M | $715.5M | ||
| Q3 25 | $546.6M | $759.9M | ||
| Q2 25 | $399.1M | $791.7M | ||
| Q1 25 | $361.3M | $810.8M | ||
| Q4 24 | $355.6M | $840.9M | ||
| Q3 24 | $221.7M | $667.7M | ||
| Q2 24 | $204.6M | $704.2M |
总资产SEIZLAB
| Q1 26 | — | — | ||
| Q4 25 | $2.1B | $1.2B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.1B | $1.2B | ||
| Q3 24 | $939.5M | $985.3M | ||
| Q2 24 | $457.8M | $987.4M |
负债/权益比SEIZLAB
| Q1 26 | — | — | ||
| Q4 25 | 0.33× | — | ||
| Q3 25 | 0.70× | — | ||
| Q2 25 | 0.97× | — | ||
| Q1 25 | 0.88× | — | ||
| Q4 24 | 0.89× | — | ||
| Q3 24 | 1.42× | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-26.7M |
| 自由现金流率自由现金流/营收 | — | -21.0% |
| 资本支出强度资本支出/营收 | 175.0% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流SEIZLAB
| Q1 26 | — | — | ||
| Q4 25 | $95.9M | $-26.0M | ||
| Q3 25 | $63.3M | $-32.0M | ||
| Q2 25 | $24.2M | $-31.0M | ||
| Q1 25 | $25.7M | $-61.7M | ||
| Q4 24 | $13.1M | $-55.8M | ||
| Q3 24 | $10.5M | $-26.8M | ||
| Q2 24 | $18.9M | $-42.2M |
自由现金流SEIZLAB
| Q1 26 | — | — | ||
| Q4 25 | $-158.6M | $-26.7M | ||
| Q3 25 | $462.0K | $-35.0M | ||
| Q2 25 | $-160.9M | $-33.9M | ||
| Q1 25 | $-118.6M | $-63.2M | ||
| Q4 24 | $-113.6M | $-58.4M | ||
| Q3 24 | $-47.2M | $-28.2M | ||
| Q2 24 | $18.2M | $-42.9M |
自由现金流率SEIZLAB
| Q1 26 | — | — | ||
| Q4 25 | -88.2% | -21.0% | ||
| Q3 25 | 0.3% | -30.4% | ||
| Q2 25 | -107.8% | -31.1% | ||
| Q1 25 | -93.9% | -59.9% | ||
| Q4 24 | -117.9% | -53.8% | ||
| Q3 24 | -63.0% | -27.7% | ||
| Q2 24 | 24.7% | -42.9% |
资本支出强度SEIZLAB
| Q1 26 | 175.0% | — | ||
| Q4 25 | 141.6% | 0.5% | ||
| Q3 25 | 37.6% | 2.6% | ||
| Q2 25 | 124.0% | 2.6% | ||
| Q1 25 | 114.2% | 1.5% | ||
| Q4 24 | 131.5% | 2.4% | ||
| Q3 24 | 77.0% | 1.3% | ||
| Q2 24 | 0.9% | 0.7% |
现金转化率SEIZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 4.35× | — | ||
| Q2 25 | 2.02× | — | ||
| Q1 25 | 4.83× | — | ||
| Q4 24 | 2.10× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.04× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SEI
| Leasing revenue | $105.4M | 54% |
| Service revenue | $90.9M | 46% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
